N01191 104 — Philadelphia, Pennsylvania

N01191 104 is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

N01191 104 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy, Partial.

Sponsors: UCB S.A. - Pharma Sector.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01191 104?

N01191 104 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01191 104 conducted?

N01191 104 has 1 clinical trials on record. Their work covers Epilepsy, Partial.

Is N01191 104 accredited by Crixeo Health?

N01191 104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01191 104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.